Advertisement

Coronaviruses pp 339-346 | Cite as

Neurotropism of Human Coronavirus 229E

  • Pierre J. Talbot
  • Sophie Ékandé
  • Neil R. Cashman
  • Samir Mounir
  • Janet N. Stewart
Chapter
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 342)

Abstract

The 299E prototype strain of human coronavirus (HCV-229E) has so far been mainly associated with infections of the respiratory tract. In the present study, we show evidence for infection of the central nervous system (CNS) by HCV-229E, both in vitro and in vivo.

Various human cell lines of CNS origin were tested for their susceptibility to infection by HCV-229E. Production of viral antigens was monitored by indirect immunofluorescence with monoclonal antibodies and infectious progeny virions by plaque assay on the L132 human embryonic lung cell line. The SK-N-SH neuroblastoma and H4 neuroglioma cell lines were highly susceptible to infection. The U-87 MG and U-373 MG astrocytoma cell lines were also infectable by HCV-229E. We could also demonstrate infection of the MO3.13 cell line, which was established by fusion of human oligodendrocytes with a thioguanineresistant mutant of the TE671 (RD) human rhabdomyosarcoma cell line. An apparently more extensive infection of the MO3.13 cells, when compared to the parental cells, supports the notion that human oligodendrocytes are differentially susceptible to infection by this virus.

We also tested for HCV-229E gene expression in pathological brain specimens. For that purpose, we developed a reverse transcription-polymerase chain reaction (RT-PCR) assay to amplify a portion of the mRNA encoding the viral nucleocapsid protein. Using stringent laboratory conditions, viral RNA was detectable in brain tissue of 4 of 11 multiple sclerosis patients and none of 6 neurological and 5 normal controls.

These results strongly suggest neurotropism on the part of HCV-229E and emphasize the importance of further studies on the possible involvement of human coronaviruses in neurological diseases such as multiple sclerosis.

Keywords

Multiple Sclerosis Central Nervous System Tissue Astrocytoma Cell Line Glial Cell Line Human Coronaviruses 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    K. McIntosh, In: “Virology, 2nd edn.”, B.N. Fields, D.M. Knipe et al., eds., p. 857, Raven Press, New York (1990).Google Scholar
  2. 2.
    N. Riski, and T. Hovi. J. Med. Virol. 6: 259 (1980).PubMedCrossRefGoogle Scholar
  3. 3.
    S. Resta, J.P. Luby, C.R. Rosenfeld, and J.D. Siegel. Science 229: 978 (1985).PubMedCrossRefGoogle Scholar
  4. 4.
    M. Battaglia, N. Passarini, A. DiMatteo, and G. Gerna. J. Inf. Dis. 155: 140 (1987).CrossRefGoogle Scholar
  5. 5.
    M.L. Mortensen, C.G. Ray, C.M. Payne, A.D. Friedman, L.L. Minnich, and C. Rousseau. Amer. J. Dis. Child. 139: 928 (1985).PubMedGoogle Scholar
  6. 6.
    R. Tanaka, Y. Iwasaki, and H.J. Koprowski. J. Neurol. Sci. 28: 121 (1976).PubMedCrossRefGoogle Scholar
  7. 7.
    J.S. Burks, B.L. DeVald, L.D. Jankovsky, and J.C. Gerdes. Science 209: 933 (1980).PubMedCrossRefGoogle Scholar
  8. 8.
    S. Weiss. Virology 126: 669 (1983).PubMedCrossRefGoogle Scholar
  9. 9.
    R.S. Murray, B. Brown, D. Brian, and G.F. Cabirac. Ann. Neurol. 31: 525 (1992).PubMedCrossRefGoogle Scholar
  10. 10.
    R.S. Murray, G.-Y. Cai, K. Hoel, J.Y. Zhang, K.F. Soike, and G.F. Cabirac. Virology 188: 274 (1992).PubMedCrossRefGoogle Scholar
  11. 11.
    A. Salmi, B. Ziola, T. Hovi, and M. Reunanen. Neurology 32: 292 (1982).PubMedCrossRefGoogle Scholar
  12. 12.
    V. ter Meulen, P.T. Massa, and R. Dörries. In: “Handbook of Clinical Neurology: Viral Disease, Revised Series”, P.J. Vinken, G.W. Bruyn, and H.L. Klawans, eds., Vol. 12 (56), p. 439, Elsevier, New York (1989).Google Scholar
  13. 13.
    J. Pearson, and C.A. Mims. J. Virol. 53: 1016 (1985).PubMedGoogle Scholar
  14. 14.
    A.R. Collins, and O. Sorensen. Microbial Path. 1: 573 (1986).CrossRefGoogle Scholar
  15. 15.
    D. Harare, and J.J. Procknow. Proc. Soc. Exp. Biol. Med. 121: 190 (1966).Google Scholar
  16. 16.
    P. Jouvenne, S. Mounir, J.N. Stewart, C.D. Richardson, and P.J. Talbot. Virus Res. 22: 125 (1992).PubMedCrossRefGoogle Scholar
  17. 17.
    N. Arpin, and P.J. Talbot. In: “Coronaviruses and Their Diseases”, D. Cavanagh and T.D.K. Brown, eds., p. 73, Plenum Press, New York (1990).CrossRefGoogle Scholar
  18. 18.
    G. Trudel, J. Antel, and N.R. Cashman. Soc. Neurosci. Abst. 17: 31(1991).Google Scholar
  19. 19.
    P. Chomczynski, and N. Sacchi. Anal. Biochem. 162: 156 (1987).PubMedCrossRefGoogle Scholar
  20. 20.
    J.N. Stewart, S. Mounir, and P.J. Talbot. In: “Diagnosis of Human Viruses by the Polymerase Chain Reaction, Frontiers in Virology, Vol. 1”, Y. Becker and G. Darai, eds., p. 316, Springer Verlag, Berlin (1992).CrossRefGoogle Scholar
  21. 21.
    S.S. Schreiber, T. Kamahora, and M.M.C. Lai. Virology 169: 142 (1989).PubMedCrossRefGoogle Scholar
  22. 22.
    R.K. Saiki, D.H. Gelfand, S. Stoffel, S.J. Scharf, R. Higuchi, G.T. Horn, K.B. Mullis, and H.A. Erlich. Science 239: 487 (1988).PubMedCrossRefGoogle Scholar
  23. 23.
    E. Southern. Methods Enzymol. 68: 152 (1979).PubMedCrossRefGoogle Scholar
  24. 24.
    H. Wege, S. Siddell, and V. ter Meulen. Curr. Top. Microbiol. Immunol. 99: 165 (1982).PubMedCrossRefGoogle Scholar
  25. 25.
    O. Sorensen, A. Collins, W. Flintoff, G. Ebers, and S. Dales. Neurology 36: 1604 (1986).PubMedCrossRefGoogle Scholar
  26. 26.
    R.E. Gama, P.J. Hughes, C.B. Bruce, and G. Stanway. Nucl. Acids Res. 16: 9346 (1988).PubMedCrossRefGoogle Scholar
  27. 27.
    S. Perlman, G. Jacobsen, A.L. Olson, and A. Afifi. Virology 175: 418 (1990).PubMedCrossRefGoogle Scholar
  28. 28.
    T.H. Maugh II. Science 195: 768 (1977).PubMedCrossRefGoogle Scholar
  29. 29.
    P. Talbot, and P. Jouvenne. Médecinel Sciences 8: 119 (1992).Google Scholar
  30. 30.
    K. Ota, M. Matsui, E.L. Milford, Mackin, G.A., H.L. Weiner, and D.A. Hafler. Nature 346: 183 (1990).PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1994

Authors and Affiliations

  • Pierre J. Talbot
    • 1
  • Sophie Ékandé
    • 1
  • Neil R. Cashman
    • 2
  • Samir Mounir
    • 1
  • Janet N. Stewart
    • 1
  1. 1.Centre de Recherche en Virologie Institut Armand-FrappierUniversité du QuébecLavalCanada
  2. 2.Montreal Neurological InstituteMcGill UniversityMontrealCanada

Personalised recommendations